| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 14.09.2011 (4808
dage). |
| Historik | Start | Stop |
|---|
| NORMAL | 14.09.2011 | |
| UNDER FRIVILLIG LIKVIDATION | 28.05.2010 | 13.09.2011 |
| NORMAL | 06.07.2009 | 27.05.2010 |
| Branche | | Engroshandel med medicinalvarer og sygeplejeartikler (464610). |
| Sidst opdateret den 16.03.2012 og
angivet som gældende fra 01.01.2012 (4699
dage). |
| Historik | Start | Stop |
|---|
| Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 01.01.2012 | |
| Uoplyst (999999) | 06.07.2009 | 31.12.2011 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 06.07.2009 (5608
dage). |
Ingen historik.
| Revisor | | KPMG P/S |
| Sidst opdateret den 09.05.2016 og
angivet som gældende fra 20.04.2016 (3128
dage). |
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | Pharmanovia A/S. |
| Sidst opdateret den 24.06.2021 og
angivet som gældende fra 16.06.2021 (1245
dage). |
| Historik | Start | Stop |
|---|
| Pharmanovia A/S | 16.06.2021 | |
| Atnahs Pharma Nordics A/S | 18.06.2020 | 15.06.2021 |
| PHARMANOVIA A/S | 21.05.2013 | 17.06.2020 |
| NORDMEDICA INTERNATIONAL A/S | 14.09.2011 | 20.05.2013 |
| NMAS A/S | 06.07.2009 | 13.09.2011 |
| Binavne | | Atnahs Pharma Nordics A/S. |
| Sidst opdateret den 24.06.2021 og
angivet som gældende fra 24.06.2021 (1237
dage). |
| Historik | Start | Stop |
|---|
| Atnahs Pharma Nordics A/S | 24.06.2021 | |
| Pharmanovia Nordic A/S | 24.06.2021 | |
| Pharmanovia Nordics A/S | 24.06.2021 | |
| NORDMEDICA INTERNATIONAL A/S | 06.07.2009 | |
| Pharmanovia A/S | 19.06.2020 | 23.06.2021 |
| PHARMANOVIA A/S | 06.07.2009 | 21.05.2013 |
| Tegningsregel | | Selskabet tegnes af bestyrelsens medlemmer hver for sig eller af en direktør alene. |
| Sidst opdateret den 15.10.2019 og
angivet som gældende fra 15.10.2019 (1855
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | bestyrelsesmedlemmer_hver_for_sig |
| 1 direktør |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af bestyrelsens medlemmer hver for sig eller af en direktør alene | 15.10.2019 | |
| Selskabet tegnes af direktøren i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer
i forening | 24.10.2018 | 14.10.2019 |
| Selskabet tegnes af en direktør i forening med formanden eller af en direktør i forening med næstformanden, eller af 2 medlemmer af bestyrelsen eller af den samlede bestyrelse | 04.04.2016 | 23.10.2018 |
| Selskabet tegnes af en direktør i forening med formanden eller næstformanden, af 2 medlemmer af bestyrelsen eller af den samlede bestyrelse | 21.05.2013 | 03.04.2016 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:KPMG, Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):Basis for conclusion
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Pharmanovia A/S for the financial year 1 April 2023 - 31 March 2024, which comprise income statement, balance sheet, statement of changes in equity, notes and a summary of significant accounting policies, for the Company. The financial statements are prepared under the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 March 2024, and of the results of the Company's operations for the financial year 1 April 2023 - 31 March 2024 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review
Management is responsible for Management’s Review.
Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration